Heron Therapeutics Inc (HRTX)
1.245
+0.04
(+2.89%)
USD |
NASDAQ |
Nov 14, 16:00
1.245
0.00 (0.00%)
After-Hours: 16:56
Heron Therapeutics Profit Margin (Quarterly): -25.64% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -25.64% |
| March 31, 2024 | -9.11% |
| December 31, 2023 | -31.33% |
| September 30, 2023 | -79.56% |
| June 30, 2023 | -132.4% |
| March 31, 2023 | -110.6% |
| December 31, 2022 | -66.17% |
| September 30, 2022 | -157.8% |
| June 30, 2022 | -204.0% |
| March 31, 2022 | -272.4% |
| December 31, 2021 | -264.6% |
| September 30, 2021 | -225.6% |
| June 30, 2021 | -271.9% |
| March 31, 2021 | -262.8% |
| December 31, 2020 | -302.3% |
| September 30, 2020 | -291.7% |
| June 30, 2020 | -243.5% |
| March 31, 2020 | -203.1% |
| December 31, 2019 | -165.1% |
| September 30, 2019 | -78.82% |
| June 30, 2019 | -137.0% |
| March 31, 2019 | -199.4% |
| December 31, 2018 | -171.8% |
| September 30, 2018 | -193.8% |
| June 30, 2018 | -223.8% |
| Date | Value |
|---|---|
| March 31, 2018 | -451.8% |
| December 31, 2017 | -621.6% |
| September 30, 2017 | -488.4% |
| June 30, 2017 | -502.9% |
| March 31, 2017 | -1.39K% |
| December 31, 2016 | -3.75K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-302.3%
Minimum
Dec 2020
-9.11%
Maximum
Mar 2024
-174.7%
Average
-203.1%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Journey Medical Corp | -22.63% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -22.10% |
| Return on Invested Capital | -35.80% |
| Gross Profit Margin (Quarterly) | 70.80% |
| Operating Margin (Quarterly) | -17.89% |
| Return on Net Operating Assets | -35.51% |